Patients with essential thrombocythemia (ET) can experience hemorrhagic or ischemic
vascular events. The prevention of these complications is challenging, and the overall risk of …

Background Essential thrombocythemia (ET) is a myeloproliferative neoplasm characterized
by elevated and dysfunctional platelets. ET can result in systemic thrombotic and …

Background Our aim was to assess the incidence and the special characteristics of stroke,
as a severe complication of patients diagnosed with essential thrombocythemia (ET) …

Although essential thrombocythemia (ET) may involve thrombotic complications, including
arterial or venous thrombosis, there are no reports of major vascular complications …

Essential thrombocythemia (ET) represents a risk factor for ischemic stroke, although it is a
rare cause. Chronic myeloproliferative disorder is associated with proliferation of …

Essential thrombocytemia (ET) is a clonal myeloproliferative disorder of unknown cause,
characterized by an increased number of apparently normal platelets. It has been related to …

Background Essential thrombocythemia (ET) is known to be associated with an increased
vascular event, but the stroke patterns and prognosis have not been studied. Methods …

Discussion The incidence of ischemic stroke associated with ET is rare, which has been
reported to be 0.25–0.5%. The primary objective of treatment of ET is to prevent …

Background Essential thrombocythemia (ET) is considered a rare cause of stroke partly
because it is not detected if the platelet count is not elevated. However, early detection of ET …

A case of essential thrombocythemia (ET) associated with subdural hematoma and
postoperative intracerebral hemorrhage was reported. A 57-year-old man had complained …